Anika Therapeutics (ANIK) Revenue Growth (3y) (2013 - 2026)
Anika Therapeutics (ANIK) Revenue Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 2.22% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 4.22% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -0.31% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 9.51% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -1.40% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 28.43% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 8.98% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Anika Therapeutics | 282.86 Mn | 244.45 Mn | 21.24 Mn | -9.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.71% |
| Mar 31, 2026 | -7.92% |
| Dec 31, 2025 | 135.04% |
| Sep 30, 2025 | -11.60% |
| Jun 30, 2025 | -10.72% |
| Mar 31, 2025 | -10.66% |
| Dec 31, 2024 | -5.11% |
| Sep 30, 2024 | -9.24% |
| Jun 30, 2024 | -6.96% |
| Mar 31, 2024 | -5.41% |
| Dec 31, 2023 | -27.83% |
| Sep 30, 2023 | 9.37% |
| Jun 30, 2023 | 13.03% |
| Mar 31, 2023 | 2.33% |
| Dec 31, 2022 | -27.93% |
| Sep 30, 2022 | 10.68% |
| Jun 30, 2022 | 9.24% |
| Mar 31, 2022 | 14.07% |
| Dec 31, 2021 | 9.94% |
| Sep 30, 2021 | 13.86% |